Cancer Family
Thoracic Neoplasm
CI-CAN-00000054Explore in graph →
Non-malignant2,891 active trials51 approved drugs626 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000054Explore in graph →
Clinical trials
12,160 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01410214 | Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations | unknown | Phase 2 | 80 | Chinese Lung Cancer Surgical GroupOTHER | 1 | Dec 23, 2011 | clinicaltrials |
| NCT01497041 | A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment | unknown | Phase 2 | 35 | Korean South West Oncology GroupNETWORK | 1 | Dec 22, 2011 |
| clinicaltrials |
| NCT00620269 | Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III | unknown | Phase 2 | 212 | National Cancer Center, KoreaOTHER_GOV | 1 | Nov 7, 2011 | clinicaltrials |
| NCT01429766 | A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients | unknown | Phase 2 | 100 | Tata Memorial HospitalOTHER_GOV | 1 | Sep 7, 2011 | clinicaltrials |
| NCT01417806 | Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer | unknown | Phase 2 | 28 | South Florida Veterans Affairs Foundation for Research and EducationFED | 1 | Aug 16, 2011 | clinicaltrials |
| NCT01097317 | First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 | 52 | Wales Cancer Trials UnitOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT01391260 | Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 30 | ZhuGuangYingINDUSTRY | 1 | Aug 2, 2011 | clinicaltrials |
| NCT01401192 | Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression | unknown | Phase 2 | 304 | Samsung Medical CenterOTHER | 1 | Jul 25, 2011 | clinicaltrials |
| NCT01203735 | Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 20 | Soroka University Medical CenterOTHER | 1 | Mar 29, 2011 | clinicaltrials |
| NCT01312337 | Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 92 | Samsung Medical CenterOTHER | 1 | Mar 10, 2011 | clinicaltrials |
| NCT00178698 | Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors(FR-WB-TT/che) | unknown | Phase 2 | 36 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT00083083 | Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 250 | American College of Radiology Imaging NetworkNETWORK | 3 | Mar 1, 2011 | clinicaltrials |
| NCT01305967 | Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer | unknown | Phase 2 | 20 | SBPharmaceutical IND, Co., LTDINDUSTRY | 1 | Mar 1, 2011 | clinicaltrials |
| NCT00736814 | First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | unknown | Phase 2 | 117 | Yonsei UniversityOTHER | 1 | Feb 24, 2011 | clinicaltrials |
| NCT00886678 | A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)(NSCLC) | unknown | Phase 2 | 63 | Zhejiang Cancer HospitalOTHER | 1 | Feb 24, 2011 | clinicaltrials |
| NCT01260480 | An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation | unknown | Phase 2 | 60 | Aposense Ltd.INDUSTRY | 1 | Dec 17, 2010 | clinicaltrials |
| NCT00452881 | Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC | unknown | Phase 2 | 151 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT00453115 | Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 43 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT00874328 | A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 74 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT01210053 | Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 30 | Third Military Medical UniversityOTHER | 1 | Sep 28, 2010 | clinicaltrials |
| NCT01192230 | Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT01192243 | Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients | unknown | Phase 2 | 68 | Fudan UniversityOTHER | 1 | Sep 3, 2010 | clinicaltrials |
| NCT01187290 | Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases | unknown | Phase 2 | 80 | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Aug 24, 2010 | clinicaltrials |
| NCT01170923 | FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 100 | Asan Medical CenterOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00452803 | Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 102 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT01158144 | Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) | unknown | Phase 2 | 134 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00563160 | Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery | unknown | Phase 2 | 50 | Hospital Authority, Hong KongOTHER_GOV | 1 | Jul 7, 2010 | clinicaltrials |
| NCT01145924 | Transbronchial Needle Forceps for Endobronchial Ultrasound | unknown | Phase 2 | 50 | Heidelberg UniversityOTHER | 1 | Jun 17, 2010 | clinicaltrials |
| NCT01131429 | A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations | unknown | Phase 2 | 60 | Chinese PLA General HospitalOTHER | 1 | May 27, 2010 | clinicaltrials |
| NCT01130779 | The Continuation of Erlotinib | unknown | Phase 2 | 23 | Samsung Medical CenterOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01091376 | Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)(RT0901) | unknown | Phase 2 | 75 | Zhejiang Cancer HospitalOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT00862004 | Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung Cancer | unknown | Phase 2 | 30 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT01054482 | Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 120 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT01051362 | Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 48 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 18, 2010 | clinicaltrials |
| NCT00516100 | Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC | unknown | Phase 1 / Phase 2 | 62 | Aptium Oncology Research NetworkNETWORK | 1 | Jan 15, 2010 | clinicaltrials |
| NCT01048970 | Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 14, 2010 | clinicaltrials |
| NCT00997724 | Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer(VATS) | unknown | Phase 2 | 100 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT01019798 | Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer | unknown | Phase 2 | 16 | Taipei Medical University HospitalOTHER | 1 | Nov 25, 2009 | clinicaltrials |
| NCT00568841 | Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)(ERLOPET) | unknown | Phase 2 | 40 | Lung Cancer Group CologneOTHER | 1 | Sep 17, 2009 | clinicaltrials |
| NCT00964132 | Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 48 | NuRx Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 3, 2009 | clinicaltrials |
| NCT00801385 | Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy | unknown | Phase 2 | 47 | Yonsei UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00786331 | Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC | unknown | Phase 2 | 230 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00938418 | Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 43 | National University Hospital, SingaporeOTHER | 1 | Jul 13, 2009 | clinicaltrials |
| NCT00923637 | Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer | unknown | Phase 2 | 75 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 18, 2009 | clinicaltrials |
| NCT00908336 | Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen | unknown | Phase 2 | 70 | Hospital Arnau de VilanovaOTHER | 1 | May 25, 2009 | clinicaltrials |
| NCT00905983 | Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 48 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 | clinicaltrials |
| NCT00906061 | Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 76 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 | clinicaltrials |
| NCT00886028 | Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma | unknown | Phase 2 | 31 | National Institute of CancerologíaOTHER_GOV | 1 | Apr 22, 2009 | clinicaltrials |
| NCT00722969 | Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer | unknown | Phase 2 | 48 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00270582 | A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer | unknown | Phase 2 | 58 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Dec 23, 2011source: clinicaltrials